Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2015-07-08 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
2015年第二次临时股东大会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2015 second extraordinary general meeting of shareholders of Shandong Ruikang Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the official voting outcomes and procedural compliance rather than presenting a full report or financial statements. The document length is short (1741 characters), and it serves as an official declaration of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2015-07-08 Chinese
关于筹划非公开发行股票停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shandong Ruikang Pharmaceutical Co., Ltd. regarding the progress of a non-public stock issuance and the related trading suspension (停牌) of the company's shares. It details the dates of previous announcements about the suspension and states that the stock will continue to be suspended to protect investors and avoid price volatility. The document is short (868 characters) and focuses on the status update of a capital raising activity (non-public stock issuance). It is not a full financial report, audit, or earnings release, nor is it a voting result or management change. The content fits best under Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes.
2015-07-07 Chinese
2014年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2014 annual equity distribution (dividend) plan of Shandong Ruikang Pharmaceutical Co., Ltd. It details the dividend amount per share, the record date, the ex-dividend date, the dividend recipients, and the method of dividend distribution. It also references the approval of the plan at the 2014 annual general meeting and includes contact information for inquiries. The document is short (1252 characters) and serves as a formal notice of dividend distribution rather than a full financial report or detailed annual report. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2015-07-03 Chinese
关于筹划非公开发行股票延期复牌公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the extension of a trading suspension related to the planning of a non-public stock issuance. It references previous suspension announcements and states that the stock will continue to be suspended until the non-public issuance plan is completed. There are no financial statements, detailed financial data, or report contents included. The document is a regulatory announcement about capital raising activities and stock trading status, not the actual financing report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification.
2015-06-30 Chinese
关于筹划非公开发行股票停牌进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shandong Ruikang Pharmaceutical Co., Ltd. regarding the progress of a trading suspension due to the planning of a non-public stock issuance. It details the dates of suspension and progress announcements and states the expected resumption date. The content focuses on the status of a capital raising activity (non-public stock issuance) and the related trading halt. It is not a full financial report, earnings release, or management discussion. It is an update on financing activity and stock trading status, fitting the Capital/Financing Update category.
2015-06-25 Chinese
关于召开2015年第二次临时股东大会的通知（更新后）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2015 second extraordinary general meeting of shareholders for Shandong Ruikang Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), registration details, agenda items to be voted on, and proxy authorization forms. There is no financial data or report content, but rather an announcement and instructions related to the shareholder meeting. The document length is 4314 characters, which is relatively short and consistent with a meeting notice rather than a full report. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2015-06-24 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.